Home/Filings/4/0000899243-20-023197
4//SEC Filing

TOMBESI PAOLO 4

Accession 0000899243-20-023197

CIK 0001571498other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 4:15 PM ET

Size

8.6 KB

Accession

0000899243-20-023197

Insider Transaction Report

Form 4
Period: 2020-08-19
TOMBESI PAOLO
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock, par value $0.0001

    2020-08-20$12.55/sh2,091$26,24226,906 total
  • Exercise/Conversion

    Restricted Stock Units

    2020-08-19+7,05521,162 total
    Common Stock (7,055 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2020-08-19+7,05528,997 total
Footnotes (2)
  • [F1]Restricted Stock Units convert into common stock on a one-for-one basis.
  • [F2]On August 19, 2019, the reporting person was granted 28,217 restricted stock units, vesting in four equal annual installments beginning August 19, 2020.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1
  • filerCIK 0001707648

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:15 PM ET
Size
8.6 KB